Table 4.
Overview of recent studies evaluating stent retrievers.
| Primary used stent retriever | Number of patients | First-pass reperfusion rate (%) | Final reperfusion rate (%) | |||
|---|---|---|---|---|---|---|
| mTICI | ≥2b | ≥2c | ≥2b | ≥2c | ||
| Trevo 2000 Registry (7, 13) | Trevo XP | 2,008 | - | 27.8% | 92.8% | 56.4%a |
| Yi et al. (14) | Trevo XP | 98 | 40.8% | 89.7% | ||
| Solitaire | 102 | 32% | 82.3% | |||
| ARISE II (15) | EmboTrap I and II | 227 | 51.5% | 40% | 92.5% | 76% |
| Ribo et al. (16) | Neva thrombectomy device | 30 | 63% | 47% | 93% | 63% |
| Velioglu et al. (17) | CatchView thrombectomy device | 53 | 47.2% | - | 84.9% | - |
| Gupta et al. (18) | Tigertriever | 160 | 57.8% | - | 95.7% | 71.8% |
| Kurre et al. (19) | pREset stent retriever | 271 | - | - | 84.9% | - |
| ARTESp (20) | pREset stent retriever | 100 | - | - | 85.3% | - |
| Kaschner et al. (21) | Aperio thrombectomy device | 97 | 43.9% | 15.1% | 85.3% | 54.8% |
| Kaschner et al. (22) | Aperio Hybrid stent retriever | 48 | 52.1% | 31.3% | 95.8% | 60.4% |
| Pfaff et al. (23) | Solitaire Platinum stent retriever | 75 | 38.6% | 92% | ||
| Our study | Trevo NXT ProVue retriever | 80 | 63.75% | 53.75% | 96.25% | 82.5% |
a
Refers to mTICI 3 results.
mTICI, modified thrombolysis in cerebral infarction.